ValueScreener

ValueScreener company report

Pulsenmore Ltd. Ordinary Shares (PLSM)

NASDAQ / Healthcare / Medical - Devices

Share price

1.81 USD Market dataClose of Oct 15, 2026

Market capitalisation

11.8M USD Market dataClose of Oct 15, 2026
Market data
Oct 15, 2026
Filed accounts
FY2025, filed Mar 30, 2026
Ratios computed
Oct 15, 2026
Filed years
3, FY2023 to FY2025
Four kinds of sourceSEC filingCompany statementMarket dataComputedWhat each means
SEC filingFiled with the SEC
Read from a statement the company filed with the SEC, with the form, fiscal year, filing date and accession beside it.
Company statementCompany statement
What the company says about itself in a filing: an 8-K item, the auditor, its own segment names.
Market dataMarket data
Prices, market value and what analysts publish, with the date they are as of.
ComputedComputed by ValueScreener
Worked out by us from the other three, with the inputs and the formula one press away. A score is a research output, not a rating or a recommendation.
Reading

1 of 10

Overview

What the business is, what it costs, and how it reads on four questions.

Market dataSEC filingComputed

Four questions, at a glance

Quality

Return on equity

-19.1% Computed

From the FY2025 filing

Read quality

Valuation

Price to book

0.44x Computed

FY2025 accounts, priced at the latest close

Read valuation

Cash generation

Free cash flow yield

-90.5% Computed

FY2025 accounts, priced at the latest close

Read cash generation

Revenue and net income, by fiscal year

FY2019 Net income: -4.6M ILSFY2023 Revenue: 6.2M ILSFY2023 Net income: -58.6M ILSFY2024 Revenue: 9.7M ILSFY2024 Net income: -36.7M ILSFY2025 Revenue: 40.0M ILSFY2025 Net income: -15.9M ILS
Revenue Net income4 fiscal years; a year whose statement names no SEC filing is market data, and the table in Filings says which.
Named tests met
1 of 30 Which tests
The business, and the score behind its five axes

The reading, in brief

Is it good

Return on equity was -19.1% in FY2025, in the band labelled "Likely below the cost of equity" (below 8.0%), on lines anchored on Damodaran's cost-of-capital data, suggesting returns on shareholders' money below the usual cost of equity.

Today, against the Medical - Devices industry (111 companies), -19.1% sits at the 58th percentile; the middle half of that group runs from -133.7% to 5.1%.

Is it safe

Current ratio was 7.88 in FY2025, in the band labelled "At or above Graham's requirement" (2.00 and above), on lines anchored on Graham's defensive-investor criteria, suggesting short-term assets well above short-term obligations.

Today, against the Medical - Devices industry (121 companies), 7.88 sits at the 89th percentile; the middle half of that group runs from 1.73 to 5.07.

Year by year against peers
Whether Pulsenmore Ltd. Ordinary Shares's return on equity stayed above the median of the Medical - Devices industry, year by year. (FY2024 to FY2025, 2 fiscal years of Pulsenmore Ltd. Ordinary Shares with a comparable figure)
What could explain it
What in Pulsenmore Ltd. Ordinary Shares's filed statements could explain the movements. (4 readings drawn from the statement lines Pulsenmore Ltd. Ordinary Shares filed)
What to check next
What to check next on Pulsenmore Ltd. Ordinary Shares, and where in its filings. (3 questions for Pulsenmore Ltd. Ordinary Shares)
In one paragraph
One paragraph on Pulsenmore Ltd. Ordinary Shares's returns, cash, balance sheet and price. (5 of sixteen figures read for Pulsenmore Ltd. Ordinary Shares)

These are PLSM’s filed figures. The research desk says what they mean, against peers and its own years, with what to check next.

Research PLSMPart of Serious. New accounts start with 30 days of Professional, free, no card.

2 of 10

What changed

The newest filing, what it moved, and when the next one is due.

SEC filingCompany statement

The newest accounts on file are the FY2025 annual report: 20-F, filed Mar 30, 2026, accession 0001493152-26-013485.

3 of 10

Quality

The returns the business earns on its capital, and the margins behind them.

SEC filingComputed

Pulsenmore Ltd. Ordinary Shares: returns on capital and margins, each with its source
FigureValue, source and document
Return on invested capital, after tax
Why n/a

No operating income line is filed for this year.

n/a ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Return on equity-19.1% ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Return on capital employed, pre-tax
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Return on assets-15.6% ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Gross margin84.2% ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Operating margin
Why n/a

No operating income line is filed for this year.

n/a ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Net margin-39.6% ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
PLSM -39.6%
NMTC -39.6%CVRX -94.1%QTI -111.4%SRTS -28.1%TELA -48.4%
-111.4%-28.1%
Net margin: PLSM against the 5 companies named under Valuation context, each as filed for its own latest year. Placement only: no average is drawn.

4 of 10

Financial strength

What it owes against what it owns, and whether it can meet what falls due.

SEC filingComputedCompany statement

Pulsenmore Ltd. Ordinary Shares: leverage, liquidity and distress, each with its source
FigureValue, source and document
Debt to equity
Why n/a

The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.

n/a ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Current ratio7.88 ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Quick ratio5.95 ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Interest coverage
Why n/a

No operating income line is filed for this year.

n/a ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Altman Z-score
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Net debt
Why n/a

The FY2025 balance sheet carries no net debt we could read.

n/a ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Total assets 101.8MTotal liabilities 18.8MShareholders' equity 83.1MOwnsOwes, and equity
Total assets Total liabilities Shareholders’ equity
The balance sheet, line by line

Financial health

What Pulsenmore Ltd. Ordinary Shares owned and owed at the end of fiscal 2025, from the balance sheet it filed (20-F, filed Mar 30, 2026, 0001493152-26-013485).

Pulsenmore Ltd. Ordinary Shares: balance sheet position
Total assets101.8M FiledFY2025 20-F, filed Mar 30, 2026
Total liabilities18.8M FiledFY2025 20-F, filed Mar 30, 2026
Shareholders' equity83.1M FiledFY2025 20-F, filed Mar 30, 2026
Cash21.6M FiledFY2025 20-F, filed Mar 30, 2026
Total debtn/a FiledFY2025 20-F, filed Mar 30, 2026
Net debtn/a
Current ratio7.88
Debt to equityn/a
  • Debt to equity: FY2025: The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
  • Interest cover: FY2025: No operating income line is filed for this year.

Read from the filed balance sheet for each year, with the income statement of the same year supplying operating profit where a ratio needs it. Nothing here is a view on whether this company is sound.

5 of 10

Valuation context

What the market charges for it, against its own record and companies like it.

Market dataSEC filingComputed

Pulsenmore Ltd. Ordinary Shares: what the market charges, each with its source
FigureValue, source and document
Price to earnings
Why n/m

Earnings are zero or negative, so a price to earnings multiple is not meaningful. A negative P/E is not a cheap company and a large positive one from a near-zero denominator is not an expensive one.

n/m ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
P/E on trailing twelve months
Why n/a

A trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 0 for this company. Nothing is drawn rather than a line built from fewer.

n/a ComputedClose of Oct 15, 2026 · Trailing four quarters, each as known on the day; the quarterly filings are listed under Filings
Price to book0.44x ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Price to sales0.91x ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Enterprise value to EBIT
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Enterprise value to EBITDA
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Price to earnings over growth
Why n/m

Earnings are zero or negative, so a price to earnings multiple is not meaningful. A negative P/E is not a cheap company and a large positive one from a near-zero denominator is not an expensive one.

n/m ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Diluted earnings per share
Why n/a

The FY2025 filing carries no diluted earnings per share we could read.

n/a FiledFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Graham number
Why n/m

Earnings are zero or negative, so a price to earnings multiple is not meaningful. A negative P/E is not a cheap company and a large positive one from a near-zero denominator is not an expensive one.

n/m ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485

We publish no fair value or price target of our own. Value PLSM on your own assumptions in the DCF workbench, starting from the filed figures.

Its own record, and companies like it

Valuation

What the market charges for Pulsenmore Ltd. Ordinary Shares today, and the multiples it has carried. No value of ours: the figures are the filings’ and the market’s.

Pulsenmore Ltd. Ordinary Shares: valuation
Share price1.81 USD
Market capitalisation11.8M USD
Enterprise value to EBITDAn/a
Graham numbern/m
Diluted earnings per share, FY2019n/a

Price to earnings on trailing twelve months: A trailing figure needs 4 filed quarters with the dates they were filed on, and we hold 0 for this company. Nothing is drawn rather than a line built from fewer.

Companies like Pulsenmore Ltd. Ordinary Shares

  1. NeuroOne Medical Technologies Corporation (NMTC)Market cap 9.5M USD
  2. CVRx, Inc. (CVRX)Market cap 37.0M USD
  3. QT Imaging Holdings, Inc. (QTI)Market cap 34.8M USD
  4. Sensus Healthcare, Inc. (SRTS)Market cap 45.6M USD
  5. TELA Bio, Inc. (TELA)Market cap 45.6M USD

Same industry (Medical - Devices) and size band (Nano, under 50M), nearest in market value, net margin and current ratio. Each of those counts equally, by how many of the companies considered sit between the two on it. Closest first: the order is likeness and nothing else.

6 of 10

Cash generation

Whether profit arrives as cash, and what is paid back to shareholders.

SEC filingComputed

Pulsenmore Ltd. Ordinary Shares: cash generation and what is paid out, each with its source
FigureValue, source and document
Free cash flow yield-90.5% ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Free cash flow-33.0M ILS ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Free cash flow margin-82.5% ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Dividend yield
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026 · FY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Payout ratio
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
FY2019 Free cash flow: -4.0M ILSFY2019 Net income: -4.6M ILSFY2023 Free cash flow: -53.6M ILSFY2023 Net income: -58.6M ILSFY2024 Free cash flow: -42.0M ILSFY2024 Net income: -36.7M ILSFY2025 Free cash flow: -33.0M ILSFY2025 Net income: -15.9M ILS
Free cash flow Net incomeProfit that arrives as cash stands level with net income; a gap year after year is worth reading about.

7 of 10

Filings

Every figure, the year it is for and the document it was read from.

SEC filingMarket data

The filed figures

Computed from the accounts this company filed with the SEC and, in a ratio with a price in it, the last close, dated on this page. Every filed figure below carries the fiscal year and the filing date its accounts were read from, and every blank carries the reason it is blank. Nothing here is a view on this company.

Pulsenmore Ltd. Ordinary Shares: the eight ratios, with the fiscal year and filing date behind each.
FigureValueYearAs of
n/mFY2025Oct 15, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
0.44xFY2025Oct 15, 2026
n/aFY2025Oct 15, 2026
n/a The filed income statement reports no operating income.
-90.5%FY2025Oct 15, 2026
n/aFY2025Mar 30, 2026
n/a No operating income line is filed for this year.
n/aFY2025Oct 15, 2026
n/a The filed cash flow statement reports no dividend paid at all. That is not the same as a filed zero, and we will not read it as one.
n/aFY2025Mar 30, 2026
n/a The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
7.88FY2025Mar 30, 2026
0.91xFY2025Oct 15, 2026
n/mFY2025Oct 15, 2026
n/m Not meaningful for this company, such as a P/E on negative earnings or a bank's EV/EBIT.
n/aFY2025Oct 15, 2026
n/a We hold no figure here and no stored reason for its absence. The gap is ours, not the company's.
2.83FY2025Mar 30, 2026
3/9FY2025Mar 30, 2026

The figures are computed from the accounts for fiscal 2025, the newest full year on file. 3 filed fiscal years on record, FY2023 to FY2025, from SEC EDGAR. Prices as of Oct 15, 2026. Ratios recomputed Oct 15, 2026. Two facts, because a recompute is not a fresh quote.

The year and the filing date name the statement each figure’s accounts are read from, and they stand even where the figure itself could not be computed: the line beneath a blank says what that statement did not carry. A figure’s name opens its formula and the filings behind it; a statement that names no SEC filing has no filing date, and reads n/a.

Ten years of filed figures, year by year

Ten years of filed figures

4 fiscal years, FY2019 to FY2025. 3 read from the annual reports Pulsenmore Ltd. Ordinary Shares filed with the SEC, each naming its filing; the rest from statements that name none, which are market data. Amounts in ILS, as reported.

Pulsenmore Ltd. Ordinary Shares: revenue, earnings, free cash flow and returns, by fiscal year, with the filing each year was read from
YearRevenueOperating incomeNet incomeEPS, dilutedFree cash flowOperating marginReturn on equityFiling
FY202540.0Mn/a-15.9Mn/a-33.0Mn/a-19.1%20-F, Mar 30, 20260001493152-26-013485
FY20249.7Mn/a-36.7Mn/a-42.0Mn/a-37.9%20-F, Mar 30, 20260001493152-26-013485
FY20236.2Mn/a-58.6Mn/a-53.6Mn/an/a20-F, Mar 30, 20260001493152-26-013485
FY2019n/a-4.2M-4.6M-0.77-4.0Mn/a-117.3%Market data, supplied Oct 15, 2026accession n/a
  • Revenue, compound annual growth FY2023 to FY2025: 154.3%
  • Earnings: Earnings was not positive in both 2019 and 2025, so a compound rate across the window is not defined. Both figures are in the table.
  • Earnings per share: Fewer than two filed years carry earnings per share.
  • Free cash flow: Free cash flow was not positive in both 2019 and 2025, so a compound rate across the window is not defined. Both figures are in the table.

Every figure in this section is a line of a filed annual statement or a ratio of two of them. Nothing here is estimated or smoothed. Earnings per share filed before a share split are put on today's share count, and say so. Nothing here is a verdict on the company.

8 of 10

Risks and guardrails

The accounting screens, the published tests, and the lines you can set to be told.

ComputedCompany statement

Pulsenmore Ltd. Ordinary Shares: accounting screens and published tests, each with its source
FigureValue, source and document
Beneish M-score2.83 ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Piotroski F-score3/9 ComputedFY2025 20-F, filed Mar 30, 2026, 0001493152-26-013485
Named tests met1 of 30 Computed
Beta
Why n/a

We do not hold this figure for this company, so there is nothing to show.

n/a ComputedClose of Oct 15, 2026

The named tests

Of 30 tests value investors published: 1 met, 17 not met, 12 we could not complete. Counts, never a score: a single figure would have to decide that meeting one investor’s criteria and meeting another’s are worth the same.

Which tests, by name(all 30)
Meets
Cheapest quarter on P/B (David Dreman)
Does not
Deep value; Large cap, low P/E; High F-score, low P/B (Joseph Piotroski); Three forensic scores; High returns and growth; Gross margin, turnover (Robert Novy-Marx); High yield, low payout; Dividends and buybacks; Low beta, profitable; Near the 52-week low; High returns, low debt; Owner earnings yield; High return on tangibles; Low P/S, rising earnings (James O'Shaughnessy); Tangible book or below; Cash-flow yield and ROIC; Clean books, high ROIC
Not measured
Defensive investor (Benjamin Graham); Earnings yield and ROIC (Joel Greenblatt); Low PEG, low debt (Peter Lynch); EV/EBITDA and coverage; ROIC at or above WACC; Z-score and coverage (Edward Altman); Two thirds of NCAV (Benjamin Graham); P/E times P/B (Benjamin Graham); Book or below, low debt (Walter Schloss); Cash-covered dividend; Cheapest quarter on P/E (David Dreman); Low P/E, growth, yield (John Neff). A test with a figure we could not read is incomplete, never met and never failed.
Figures we could not read(21)
  • Debt to Equity: The filed borrowings do not add up to a total we can stand behind: the filer's own liability subtotals leave room for debt we did not read.
  • Positive Earnings Streak: The latest filed year has no per-share earnings we can read; the test needs 10.
  • P/E Ratio: Earnings are zero or negative, so a price to earnings multiple is not meaningful. A negative P/E is not a cheap company and a large positive one from a near-zero denominator is not an expensive one.
  • EV/EBIT: We do not hold this figure for this company, so there is nothing to show.
  • Return on Invested Capital: No operating income line is filed for this year.
  • Altman Z-Score: We do not hold this figure for this company, so there is nothing to show.
  • PEG Ratio: Earnings are zero or negative, so a price to earnings multiple is not meaningful. A negative P/E is not a cheap company and a large positive one from a near-zero denominator is not an expensive one.
  • Eps Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • Rev Growth 5Y: We do not hold this figure for this company, so there is nothing to show.
  • EV/EBITDA: We do not hold this figure for this company, so there is nothing to show.
  • Interest Coverage: No operating income line is filed for this year.
  • Dividend Yield: We do not hold this figure for this company, so there is nothing to show.
  • Payout Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Share Count Change Yoy: We do not hold this figure for this company, so there is nothing to show.
  • Beta: We do not hold this figure for this company, so there is nothing to show.
  • ROIC-WACC Spread: We do not hold this figure for this company, so there is nothing to show.
  • % Above 52-Week Low: We do not hold this figure for this company, so there is nothing to show.
  • Price To Ncav: We do not hold this figure for this company, so there is nothing to show.
  • Price To Graham: Earnings are zero or negative, so a price to earnings multiple is not meaningful. A negative P/E is not a cheap company and a large positive one from a near-zero denominator is not an expensive one.
  • Dividend Coverage Ratio: We do not hold this figure for this company, so there is nothing to show.
  • Dividend Streak: We do not hold this figure for this company, so there is nothing to show.

9 of 10

Declared positions

Whether anybody here owns this company.

Positions declared by the founder: no holding in any company shown here, as of October 3, 2026.

10 of 10

Next step

What to do with what you have read.

A thesis is your reason for owning it, in your words, with the figures that must stay true. Checking those figures every night against the newest filed accounts, and telling you once when one breaks, is what the subscription adds.

More on this company

What this cannot tell you

  • 21 figures could not be read on this company, among them Debt to Equity, Positive Earnings Streak, P/E Ratio. Each blank in the table above names the rest, with its reason. 12 named tests come back incomplete because of them, which is neither met nor missed.
  • We hold 3 filed fiscal years rather than 10, so the run above is shorter than a full decade and is counted as what it is.

And the one that is true of all of it: This is what the numbers say today. It cannot tell you the day one of them stops being true. Nothing here can, because the reasons are not written down.

Running this once is arithmetic on public documents and you are welcome to it. Writing down why you own each company, in your own words and with the numbers that have to stay true for it to hold, and then having those numbers re-checked every night against the newest filed accounts, and against the latest close where a rule watches a price, is Professional, the plan a new account starts on for 30 days, one trial per person. It writes to you the day one breaks, and stays quiet when nothing does. The check runs every night at 23:30 UTC. A filing is picked up the night after it is published.

Monitor my portfolioHow this is computed

No card. 30 free days, and nothing is charged unless you choose a plan.

Analyze your own portfolio

ValueScreener · valuescreener.ai · Computed from accounts filed with the SEC by this company, read from EDGAR, and from dated closing prices. On this page a filed figure opens into its formula, its inputs and the statement, fiscal year and filing date it was read from, and a price into the day of its close. A figure that cannot show that trail says so.

A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.

Margin Notes

Once a week, what changed in the filings of US-listed companies, why it can matter to a thesis, and what deserves a closer review. Grounded in filings, not market noise.

Site map

Apps

  • Android app coming soon
  • iPhone app coming soon
ValueScreener

Discover companies, research each one to its filings, track what matters, and take your work into your own spreadsheet.

ValueScreener is a trading name of Oliva Real Estate Technologies LLC, a Delaware limited liability company. Legal notices: legal@valuescreener.ai. © 2026 Oliva Real Estate Technologies LLC. All rights reserved.

Risk disclaimer. This service is provided for research and education only. Nothing on it is investment advice, a recommendation, or an offer to buy or sell any security. Capital is at risk, and past performance does not indicate future results. Figures come from filed accounts and may be incomplete, delayed or later restated, so verify a number against the filing before you act on it.

With your permission, Google Analytics, Microsoft Clarity and HubSpot set cookies to measure how this site and the product are used, including recordings of sessions. Nothing is set unless you allow it. Privacy policy